SECsense Logo

Bright Minds Biosciences Inc. 6-K Filing: Key Insights & Compliance Report

$DRUG
Form 6-K
Filed on: 2025-02-24
Source
Bright Minds Biosciences Inc. 6-K Filing: Key Insights & Compliance Report

Here are the key insights extracted from the provided section of the financial report:

  1. Type of Filing: The document is a Form 6-K, which is a report used by foreign private issuers to disclose information that is material to their shareholders.
  2. Company Information:
  • Name: Bright Minds Biosciences Inc.
  • Address: 19 Vestry Street, New York, NY 10013.
  1. Filing Date: The report is dated February 24, 2025.
  2. Commission File Number: 001-40997.
  3. Filing Type Selection: The registrant has indicated that it files annual reports under Form 20-F, which is typically used by foreign companies to provide detailed financial information, rather than Form 40-F.
  4. Exhibits:
  • There is one exhibit included with the filing, labeled as Exhibit 99.1, which is a news release dated February 24, 2025.
  1. Signature:
  • The report is signed by Ryan Cheung, who is the Chief Financial Officer of Bright Minds Biosciences Inc.
  1. Compliance: The filing is made pursuant to the requirements of the Securities Exchange Act of 1934, indicating compliance with U.S. securities regulation.

This summary encapsulates the essential information provided in the financial report document, which is crucial for stakeholders analyzing the company's disclosures.